HemaSphere (Aug 2023)

S139: INTERIM ANALYSIS OF A REGISTRATION ENABLING STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) A CD123-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)

  • Naveen Pemmaraju,
  • Giovanni Martinelli,
  • Pau Montesinos,
  • Luca Mazzarella,
  • Daniel J. Deangelo,
  • Harry Erba,
  • Kendra Sweet,
  • Roland Walter,
  • Eric Deconinck,
  • Ollivier Legrand,
  • Eunice Wang,
  • Ahmed Aribi,
  • Matthew Ulrickson,
  • Giovanni Marconi,
  • Andrew Lane,
  • Hagop Kantarjian,
  • Callum Sloss,
  • Kara Malcolm,
  • Patrick Zweidler-Mckay,
  • Naval Daver

DOI
https://doi.org/10.1097/01.HS9.0000967468.85099.f4
Journal volume & issue
Vol. 7
p. e85099f4

Abstract

Read online

No abstracts available.